TY  - JOUR
T1  -      Antiplatelet Therapy and Kidney Function in Non-Dialysis Chronic Kidney Disease: A Two-Centre Observational Study in Nigeria
A1  - Peter K. Uduagbamen
A1  - Titilope A. Bamikefa
A1  - Adesola T. Oyelese
A1  - Shitu Abdul-Karim O
A1  - Gbemi H. Ano-Edward
A1  - Adeola A. Adeleke
A1  - Oseiga P Odafen
A1  - David O. Siden
A1  - Oluwadamilola E. Tijani
A1  - Divine-Michael Iwuh
A1  - Princess T. Adebanwi
JF  - International Journal of Pharmaceutical Research and Allied Sciences
JO  - Int J Pharm Res Allied Sci
SN  - 2277-3657
Y1  - 2024
VL  - 13
IS  - 2
DO  - 10.51847/EbWPUU4ekG
SP  - 86
EP  - 96
N2  - Antiplatelet therapy used in preventing cardiovascular events in chronic kidney disease may be associated with higher risks of bleeding, low efficacy from fewer occlusive atherosclerotic disease), attenuation of the inflammatory process, and changes in the haemogram. We prospectively determined the kidney function, the haemogram, and the lipid profile of participants with and without antiplatelet therapy. The population with a mean age of 69.21 ± 11.73 years, had more women (65.88%), p=0.001. Participants' age was positively correlated with the CKD stage, p
UR  - https://ijpras.com/article/nbsp-antiplatelet-therapy-and-kidney-function-in-non-dialysis-chronic-kidney-disease-a-two-cen-uq5iw2uc3b7hm1c
ER  -